These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 1413303)

  • 1. Inhibitors of calcium oxalate crystallization and urolithiasis.
    Grases F; Conte A; Genestar C; Costa-Bauzá A
    Urol Int; 1992; 48(4):409-14. PubMed ID: 1413303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urolithiasis, inhibitors and promoters.
    Grases F; Conte A
    Urol Res; 1992; 20(1):86-8. PubMed ID: 1736493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urolithiasis inhibitors and calculus nucleation.
    Grases F; Gil JJ; Conte A
    Urol Res; 1989; 17(3):163-6. PubMed ID: 2546313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein.
    Schwille PO; Schmiedl A; Manoharan M
    Clin Chem Lab Med; 2004 Mar; 42(3):283-93. PubMed ID: 15080561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zinc, copper and oxalocalcic urolithiasis.
    Grases F; Ruiz J; Costa-Bauzá A; Coll R; Conte A
    Urol Int; 1993; 50(4):205-8. PubMed ID: 8506591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Estimation of 24-h excretion of some promotors and inhibitors of crystallization and degree of urine saturation with calcium oxalate in calcium urinary calculi].
    Boruczkowska A
    Pol Arch Med Wewn; 1994 Oct; 92(4):289-98. PubMed ID: 7854956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mineralogical composition of urinary stones, risk factors and metabolic disturbances in patients with calcium-oxalate urolithiasis].
    Kustov AV; Strelnikov AI; Moryganov MA; Airapetyan AO; Smirnov PR; Lyalyakina EV; Toms SR
    Urologiia; 2017 Sep; (4):22-26. PubMed ID: 28952687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitors of oxalocalcic lithiasis: effects of their interactions on calcium oxalate crystallization.
    Muñoz JA; López-Mesas M; Valiente M
    Urology; 2012 Nov; 80(5):1163.e13-8. PubMed ID: 22748613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of magnesium on calcium oxalate urolithiasis.
    Su CJ; Shevock PN; Khan SR; Hackett RL
    J Urol; 1991 May; 145(5):1092-5. PubMed ID: 2016799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effect of pyrophosphate, citrate, magnesium and chondroitin sulphate in calcium oxalate urolithiasis.
    Grases F; Genestar C; Conte A; March P; Costa-Bauzá A
    Br J Urol; 1989 Sep; 64(3):235-7. PubMed ID: 2553195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idiopathic calcium oxalate urolithiasis and endogenous oxalate production.
    Baker PW; Rofe AM; Bais R
    Crit Rev Clin Lab Sci; 1996; 33(1):39-82. PubMed ID: 8833627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variations in the activity of urinary inhibitors in calcium oxalate urolithiasis.
    Grases F; Genestar C; March P; Conte A
    Br J Urol; 1988 Dec; 62(6):515-20. PubMed ID: 2851362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of overweight and obesity in calcium oxalate stone formation.
    Siener R; Glatz S; Nicolay C; Hesse A
    Obes Res; 2004 Jan; 12(1):106-13. PubMed ID: 14742848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycosaminoglycans, uric acid and calcium oxalate urolithiasis.
    Grases F; Costa-Bauzá A; March JG; Masárová L
    Urol Res; 1991; 19(6):375-80. PubMed ID: 1759332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitors of stone formation.
    Worcester EM
    Semin Nephrol; 1996 Sep; 16(5):474-86. PubMed ID: 8890402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simple method for the study of heterogeneous nucleation in calcium oxalate urolithiasis.
    Grases F; Conte A; Gil JJ
    Br J Urol; 1988 Jun; 61(6):468-73. PubMed ID: 3401655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of urinary pH and acid-base balance on the formation of calcium oxalate stone].
    Iida S
    Nihon Hinyokika Gakkai Zasshi; 1991 Jan; 82(1):33-40. PubMed ID: 2046198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic action of citrate in urolithiasis explained by chemical speciation: increase in pH is the determinant factor.
    Rodgers A; Allie-Hamdulay S; Jackson G
    Nephrol Dial Transplant; 2006 Feb; 21(2):361-9. PubMed ID: 16249202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycosaminoglycans and oxalocalcic urolithiasis.
    Grases F; Llompart I; Conte A; Coll R; March JG
    Nephron; 1994; 68(4):449-53. PubMed ID: 7870230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concentrated urine and diluted urine: the effects of citrate and magnesium on the crystallization of calcium oxalate induced in vitro by an oxalate load.
    Guerra A; Meschi T; Allegri F; Prati B; Nouvenne A; Fiaccadori E; Borghi L
    Urol Res; 2006 Dec; 34(6):359-64. PubMed ID: 16953377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.